• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Accuri Cytometers

edit

Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument.

As a result, the company is looking to develop affordable and robust cytometers.

Milestones

edit

• 
  Accuri Cytometers received $6M in Series E funding. (10/19/10)
  Posted 10/19/10 at 6:55pm via onbiovc.com
• 
  Accuri Cytometers received $1.75M in Unattributed funding. (9/1/05)
  Posted 2/24/10 at 2:18pm via sec.gov
• 
  Accuri Cytometers received $805k in Series A funding. (3/1/05)
  Posted 2/24/10 at 2:18pm via sec.gov
• 
  Accuri Cytometers received $13M in Series C funding. (7/8/08)
  Posted 2/24/10 at 2:18pm via sec.gov
• 
  Accuri Cytometers received $2M in Unattributed funding. (4/29/08)
  Posted 2/24/10 at 2:12pm via sec.gov
• 
  Accuri Cytometers received $100k in Series B funding. (9/1/07)
  Posted 2/24/10 at 2:12pm via sec.gov
• 
  Accuri Cytometers received $5M in Series B funding. (4/30/07)
  Posted 2/24/10 at 2:12pm via sec.gov
• 
  Accuri Cytometers received $4M in Series D funding. (8/10/09)
  Posted 8/11/09 at 1:03pm via onbiovc.com

Videos

Screenshots

edit

Sources

1. SEC D/A (sec.gov) [edit]
2. SEC D (sec.gov) [edit]
3. SEC D (sec.gov) [edit]
4. SEC D (sec.gov) [edit]
5. SEC D (sec.gov) [edit]
6. SEC D (sec.gov) [edit]
7. Accuri Cytometers, Inc.: Series D $4M (onbiovc.com) [edit]
8. Accuri Cytometers, Inc.: Series E $6M (onbiovc.com) [edit]